3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
4
Status
Completed
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Gynecologic
2
Other
1
Conditions
Endometrial Neoplasms
2
Overweight
1
Obesity
1
Metabolic Disturbance
1
Interventions
Cyclophosphamide
2042
Radiotherapy
1859
Cisplatin
1825
Carboplatin
1533
Gemcitabine
1434
Paclitaxel
1289
Bevacizumab
1270
Docetaxel
1202
pembrolizumab
1199
Oxaliplatin
1160
Capecitabine
1144
Fluorouracil
1061
Dexamethasone
971
Rituximab
919
Nivolumab
908
Magnetic Resonance Spectroscopy
862
Etoposide
839
Doxorubicin
823
Drug Therapy
792
Radiosurgery
776
Irinotecan
775
Cytarabine
736
fludarabine
716
Leucovorin
676
Lenalidomide
608
fludarabine phosphate
564
Temozolomide
552
Radiation
541
Filgrastim
540
Cetuximab
537
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
Trehalase
×
Clear all
NCT06855784
2026-01-27
TREMHO
University Hospital, Geneva
Phase NA
Recruiting
84 enrolled
NCT05454943
2025-10-01
READY
University of Toronto
Phase NA
Completed
178 enrolled
NCT04763902
2023-11-30
TIMESPAN
University of Utah
Phase NA
Completed
17 enrolled
NCT04783467
2023-11-30
TREND
University of Utah
Phase NA
Unknown
15 enrolled